Variation in cognitive function over time in Gaucher disease type 3

OBJECTIVE: To identify relevant efficacy parameters essential in designing clinical trials for brain-penetrant therapies for Gaucher disease, we evaluated cognitive function longitudinally in 34 patients with Gaucher disease type 3 seen at the NIH Clinical Center. METHODS: Individuals were tested wi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurology
Egile Nagusiak: Steward, Alta M., Wiggs, Edythe, Lindstrom, Taylor, Ukwuani, Somto, Ryan, Emory, Tayebi, Nahid, Roshan Lal, Tamanna, Lopez, Grisel, Schiffmann, Raphael, Sidransky, Ellen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937490/
https://ncbi.nlm.nih.gov/pubmed/31719137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008618
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak